# Effect of Ginkgo Biloba Special Extract LI 1370 on Dual-tasking in Patients With MCI

> **NCT01046292** · PHASE4 · COMPLETED · sponsor: **University Hospital, Basel, Switzerland** · enrollment: 50 (actual)

## Conditions studied

- Mild Cognitive Impairment

## Interventions

- **DRUG:** Ginkgo biloba

## Key facts

- **NCT ID:** NCT01046292
- **Lead sponsor:** University Hospital, Basel, Switzerland
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01
- **Primary completion:** 2015-02
- **Final completion:** 2015-10
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2015-10-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01046292

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01046292, "Effect of Ginkgo Biloba Special Extract LI 1370 on Dual-tasking in Patients With MCI". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01046292. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*